Ascidian Therapeutics names chief medical officer

Jay Barth, MD, has been named chief medical officer of Ascidian Therapeutics, a biotech drug development company. 

Dr. Barth has more than 25 years of experience in drug development and most recently served as chief medical officer for Lexeo Therapeutics, a gene therapy company, according to a March 20 news release from Ascidian.  

In his new role, Dr. Barth will lead clinical development across the company's ophthalmology, neurological, neuromuscular and genetically defined diseases pipelines. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast

Top 40 articles from the past 6 months